论文信息 - Abstract 1262: BLU-701 is a highly potent, brain-penetrant and WT-sparing next-generation EGFR TKI for the treatment of sensitizing (ex19del, L858R) and C797S resistance mutations in metastatic NSCLC - 字舞流文

Abstract 1262: BLU-701 is a highly potent, brain-penetrant and WT-sparing next-generation EGFR TKI for the treatment of sensitizing (ex19del, L858R) and C797S resistance mutations in metastatic NSCLC

S. Kazmirski | Ayşegül Özen | K. Hoeflich | T. Guzi | O. Ahmad | E. Perola | Joseph L. Kim | M. Dorsch | R. Woessner | Clare Medendorp | Victoria Brown | Jian Guo | Y. Timsit | A. Davis | C. Conti | D. Fernando | Scott D. Wardwell | F. Stevison | John L. Campbell | M. Iliou | Sharon Chicklas | J. Hsieh | C. Utt | Kevin A Barvian | Meredith S Eno | T. Dineen | R. Meißner